Calcium alginate beads embedded in silk fibroin as 3D dual drug releasing scaffolds

Biomaterials

Volumn 30, Issue 28, 2009, Pages 5170-5177

  Mandal, Biman B ^a   Kundu, Subhas C ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Controlled release; Drug delivery; Scaffolds; Silk fibroin; Tissue engineering

Indexed keywords

3D SCAFFOLDS; BIOACTIVE MOLECULES; BOVINE SERUM ALBUMINS; CALCIUM ALGINATE; CALCIUM ALGINATE BEADS; CELLULAR VIABILITY; CONTROLLED RELEASE; DELIVERY VEHICLE; DRUG RELEASE; ENCAPSULATED PROTEINS; FIBROBLAST CELLS; IN-VITRO; MECHANICALLY STABLE; MODEL COMPOUND; MODEL DRUGS; MOLECULAR WEIGHT MODEL; RELEASE KINETICS; RELEASE PROFILES; SCAFFOLD FABRICATION; SCANNING ELECTRON MICROSCOPIC; SILK FIBROIN; SUSTAINED RELEASE; TUNABLE PROPERTIES; WIDE SPECTRUM;

ALGINATE; BIOCOMPATIBILITY; BODY FLUIDS; CALCIUM; CALCIUM ALLOYS; CELL CULTURE; CONTROLLED DRUG DELIVERY; DIFFUSION COATINGS; DRUG PRODUCTS; MOLECULAR WEIGHT; SILK; THREE DIMENSIONAL; TISSUE ENGINEERING;

SCAFFOLDS;

BOVINE SERUM ALBUMIN; CALCIUM ALGINATE; FLUORESCEIN ISOTHIOCYANATE; INULIN; SILK FIBROIN; TISSUE SCAFFOLD;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FIBROBLAST; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL;

ALGINATES; ANIMALS; BOMBYX; CALCIUM; CATTLE; CELL ADHESION; CELL LINE; DELAYED-ACTION PREPARATIONS; FIBROBLASTS; FIBROINS; FLUORESCEIN-5-ISOTHIOCYANATE; GLUCURONIC ACID; HEXURONIC ACIDS; INULIN; SERUM ALBUMIN, BOVINE;

BOVINAE;

EID: 67849106369     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.05.072     Document Type: Article

References (43)

1. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
2. Wang X., Wenk E., Zhang X., Meinel L., Vunjak-Novakovic G., and Kaplan D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134 (2009) 81-90
3. Kirker-Head C., Karageorgiou V., Hofmann S., Fajardo R., Betz O., Merkle H.P., et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 41 (2007) 247-255
4. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., et al. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 78 (2006) 324-334
5. Deng T., Huang S., Zhou S., He L., and Jin Y. Cartilage regeneration using a novel gelatin-chondroitin-hyaluronan hybrid scaffold containing bFGF-impregnated microspheres. J Microencapsul 24 (2007) 163-174
6. Kim S.E., Park J.H., Cho Y.W., Chung H., Jeong S.Y., Lee E.B., et al. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. J Control Release 91 (2003) 365-374
7. Lee K.Y., Peters M.C., Anderson K.W., and Mooney D.J. Controlled growth factor release from synthetic extracellular matrices. Nature 408 (2000) 998-1000
8. Murphy W.L., Peters M.C., Kohn D.H., and Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21 (2000) 2521-2527
9. Uludag H., D'Augusta D., Golden J., Li J., Timony G., Reidel R., et al. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 50 (2000) 227-238
10. Ikada Y., and Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 31 (1998) 287-301
11. Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., and Ikada Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J Control Release 64 (2000) 133-142
12. Park Y.J., Ku Y., Chung C.P., and Lee S.J. Controlled release of platelet derived growth factor from porous poly(l-lactide) membranes for guided tissue regeneration. J Control Release 51 (1998) 201-211
13. Sakano S., Hasegawa Y., Murata Y., Ito T., Genda E., Iwata H., et al. Inhibitory effect of bFGF on endochondral heterotopic ossification. Biochem Biophys Res Commun 293 (2002) 680-685
14. Bourque W.T., Gross M., and Hall B.K. Expression of four growth factors during fracture repair. Int J Dev Biol 37 (1993) 573-579
15. Yu Y., Yang J.L., Chapman-Sheath P.J., and Walsh W.R. TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing. J Biomed Mater Res 60 (2002) 392-397
16. Jang J.H., and Shea L.D. Controllable delivery of non-viral DNA from porous scaffolds. J Control Release 86 (2003) 157-168
17. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 (2001) 1029-1034
18. Lee J.E., Kim K.E., Kwon I.C., Ahn H.J., Lee S.H., Cho H., et al. Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 25 (2004) 4163-4173
19. Elisseeff J., McIntosh W., Fu K., Blunk B.T., and Langer R. Controlled release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 19 (2001) 1098-1104
20. Kim H.D., and Valentini R.F. Human osteoblast response in vitro to platelet derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods. Biomaterials 18 (1997) 1175-1184
21. Raiche A.T., and Puleo D.A. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 25 (2004) 677-685
22. Klock G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40 (1994) 638-643
23. Matthew I.R., Browne R.M., Frame J.W., and Millar B.G. Subperiosteal behaviour of alginate and cellulose wound dressing materials. Biomaterials 16 (1995) 275-278
24. Laham R.J., Sellke F.W., Edelman E.R., Pearlman J.D., Ware J.A., Brown D.L., et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100 (1999) 1865-1871
25. Lee K.Y., Peters M.C., and Mooney D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release 87 (2003) 49-56
26. Meinel L., Hofmann S., Karageorgiou V., Kirker-Head C., McCool J., Gronowicz G., et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26 (2005) 147-155
27. Horan R.L., Antle K., Collette A.L., Wang Y., Huang J., Moreau J.E., et al. In vitro degradation of silk fibroin. Biomaterials 26 (2005) 3385-3393
28. Mandal B.B., and Kundu S.C. Non-bioengineered silk fibroin protein 3D scaffolds for potential biotechnological and tissue engineering applications. Macromol Biosci 8 (2008) 807-818
29. Mandal B.B., and Kundu S.C. Non-bioengineered silk gland fibroin protein: characterization and evaluation of matrices for potential tissue engineering applications. Biotechnol Bioeng 100 (2008) 1237-1250
30. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 24 (2003) 401-416
31. Uebersax L., Merkle H.P., and Meinel L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 127 (2008) 12-21
32. Li C., Vepari C., Jin H.J., Kim H.J., and Kaplan D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27 (2006) 3115-3124
33. Wang X., Wenk E., Matsumoto A., Meinel L., Li C., and Kaplan D.L. Silk microspheres for encapsulation and controlled release. J Control Release 117 (2007) 360-370
34. Hofmann S., Wong C.T., Foo P., Rossett F., Textor M., Vunjak-Novakovic G., et al. Silk fibroin as an organic polymer for controlled drug delivery. J Control Release 111 (2006) 219-227
35. Mandal B.B., Kapoor S., and Kundu S.C. Silk fibroin/polyacrylamide semi interpenetrating network hydrogels for controlled drug release. Biomaterials 30 (2009) 2826-2836
36. Wang X., Hu X., Daley A., Rabotyagova O., Cebe P., and Kaplan D.L. Nanolayer biomaterial coatings of silk fibroin for controlled release. J Control Release 121 (2007) 190-199
37. Wang X., Wenk E., Hu X., Castro G.R., Meinel L.R., Wang X., et al. Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 28 (2007) 4161-4169
38. Wang X., Zhang X., Castellot J., Herman I., Iafrati M., and Kaplan D.L. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 29 (2008) 894-903
39. Mandal B.B., and Kundu S.C. A novel method for dissolution and stabilization of non mulberry silk gland protein fibroin using anionic surfactant sodium dodecyl sulfate. Biotechnol Bioeng 99 (2008) 1482-1489
40. Nazarov R., Jin H.J., and Kaplan D.L. Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 5 (2004) 718-726
41. Liu L.S., Liu S.Q., Ng S.Y., Froix M., Ohno T., and Heller J. Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres. J Control Release 43 (1997) 65-74
42. Jin H.J., and Kaplan D.L. Mechanism of silk processing in insects and spiders. Nature 424 (2003) 1057-1061
43. Lazaris A., Arcidiacono S., Huang Y., Zhou J., Duguay F., Chretien N., et al. Spider silk fibers spun from soluble recombinant silk produced in mammalian cells. Science 295 (2002) 472-476